Observational Study of the Wellinks Solution Impact on Quality of Life and Clinical Outcomes in Patients With COPD (ASPIRE)
ASPIRE: An Observational Study of the Wellinks Solution Impact on Quality of Life and Clinical Outcomes in Patients With COPD
Sponsor: COPD Foundation
A NA clinical study on COPD and Chronic Obstructive Pulmonary Disease, this trial is completed. The trial is conducted by COPD Foundation and has accumulated 5 data snapshots since 2022. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
5 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Dec 2023 — Jul 2024 [monthly]
Completed NA
Status: Enrolling By Invitation → Completed
-
Mar 2022 — Dec 2023 [monthly]
Enrolling By Invitation NA
First recorded
Jan 2022
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- COPD Foundation
- Convexity Scientific Inc
For direct contact, visit the study record on ClinicalTrials.gov .